Author

Haris Qureshi

Institution: Yale University

Observed institutions: National Institutes of Health, Yale University, National Cancer Institute, Center for Cancer Research

OpenAlex ID: A5067719562

CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial

2020 · Nirali N. Shah, Steven L. Highfill, et al. · Journal of Clinical Oncology · 420

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study

2025 · Alexander Sanjurjo, David DeStephano, et al. · Blood · 1

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma

2026 · Alexander D. Sanjurjo, David DeStephano, et al. · Blood Neoplasia

How We Evaluate and Treat Leukemic Presentations of Mature T-Cell Lymphomas

2026 · Arjun Ravishankar, Vinisha Somaya, et al. · Cancers

Frontline chemotherapy for CD30+ non-ALCL peripheral T-cell lymphoma a multi-center retrospective analysis

2025 · Asaad Trabolsi, Sunwoo Han, et al. · Blood

Outcome of an Urban Cohort of North American Adult T-Cell Leukemia/Lymphoma Patients

2024 · Haris Qureshi, Ahmad Kiwan, et al. · Blood

Works count: 6

Citation count: 421

H-index: 1

I10-index: 1